High expression of ZEB1 has been observed in intrahepatic cholangiocarcinoma, colorectal cancer, gastric carcinoma, pancreatic cancer, esophageal squamous cell carcinoma and oral cavity carcinoma 6, suggesting that ZEB1 may contribute to the progression of these tumors. This evidence concerns the gene ZEB1 and intrahepatic cholangiocarcinoma.